INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 79 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $737 | +31.6% | 3,500 | 0.0% | 0.00% | – |
| Q1 2023 | $560 | -71.2% | 3,500 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $1,943 | -51.4% | 3,500 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $4,000 | +100.0% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $2,000 | -50.0% | 3,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,000 | -50.0% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $8,000 | -33.3% | 3,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $12,000 | – | 3,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,383,645 | $28,672,000 | 1.12% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $4,104,000 | 0.95% |
| DAFNA Capital Management LLC | 236,160 | $808,000 | 0.21% |
| Bleichroeder LP | 250,000 | $855,000 | 0.14% |
| Callan Capital, LLC | 146,200 | $500,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $1,866,000 | 0.05% |
| Polar Capital Holdings Plc | 2,500,000 | $8,550,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 70,431 | $241,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 89,878 | $307,000 | 0.03% |
| Jump Financial, LLC | 116,800 | $399,000 | 0.03% |